|
In 2004, the healthcare supply chain faced challenges that limited distributors' and manufacturers' ability to optimize ongoing efficiencies. Three years later Booz Allen Hamilton, on behalf of the Center for Healthcare Supply Chain Research, was commissioned to update the 2004 Role of Distributors study.
The updated study will show that many of these challenges have been overcome and that the industry is healthier than ever before.
The study includes:
- An evaluation of the current economic state of the industry
- An evaluation of pharmaceutical industry trends
- A set of “what-if” analyses around how the industry would fare in the absence of primary distributors
Click here to purchase the The Role of Distributors in the US Healthcare Industry.
Click here to download the Executive Summary.
|